While charitable dollars have flowed in to plug some gaps, “philanthropy cannot replace federal funding,” said Dustin Sposato ...

Healthcare has proved a vulnerable target for the firehose of cuts and policy changes President Donald Trump ordered in the ...

In the medium- to long-term, we expect Seek’s core strategic focus to revolve around protecting its ANZ business from competitive pressure, especially from Microsoft-owned LinkedIn. LinkedIn has ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA.

Crop protection constitutes the lion's 60% share of our fair value estimate, with the 40% balance from seeds. Our fair value breakdown includes 15% for APAC, 27% for Europe, 17% for North America, and ...

While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

Earlier this month, the US government announced a US$500 million (£377 million) investment to accelerate research into ...

Rather, it is the complex interactions between pupil absence and exclusions, the ongoing impacts on children with special ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...